Physician

James C Byrd, M.D., PH.D.

According to 2025 Medicare claims, James Byrd, M.D., PH.D. (NPI: 1679699748) practices rheumatology in the Wenatchee-East Wenatchee, WA market, with the plurality of this provider's patient population coming from Douglas, WA. This provider's primary affiliated billing organization is CENTRAL WASHINGTON HEALTH SERVICES ASSOCIATION (NPI: 1881642239; TIN: 910171250) and primary practice location at 98801-3201. Byrd is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), CVS ACO (ACO ID: A5407), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Byrd's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,139 traditional Medicare patients, billed 2,919 HCPCS/CPT codes, and received $155,729 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 9,577 prescription claims across 1,214 beneficiaries totaling $6,545,295 in drug costs, led by Rinvoq (Upadacitinib). 2015 DME data shows 11 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $29,880 to $155,729. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,168,581 to $6,545,295. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	280	619	$29,880
2016	316	738	$31,800
2017	312	664	$30,022
2018	442	837	$38,597
2019	1,215	3,290	$145,865
2020	1,184	2,956	$108,167
2021	1,161	2,822	$166,164
2022	1,164	2,830	$155,092
2023	1,137	2,710	$147,375
2024	1,139	2,919	$155,729

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	800	7,386	$2,168,581
2016	920	8,309	$3,101,378
2017	915	8,033	$3,864,636
2018	980	8,256	$4,278,648
2019	1,037	8,414	$4,267,122
2020	1,017	8,813	$5,410,519
2021	1,074	8,896	$6,150,583
2022	1,108	9,194	$6,874,425
2023	1,165	8,876	$6,574,177
2024	1,214	9,577	$6,545,295

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$3,092
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	657	1,123	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	716	996	$46
99441	Telephone medical discussion with physician, 5-10 minutes	172	219	$41
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	230	253	$30
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	135	146	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rinvoq	Upadacitinib	186	6,030	$1,306,663
Enbrel Sureclick	Etanercept	104	3,192	$820,498
Xeljanz	Tofacitinib Citrate	96	3,120	$592,096
Humira(Cf) Pen	Adalimumab	74	2,072	$549,503
Stelara	Ustekinumab	16	1,032	$345,689

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for James C. Byrd, M.D., PH.D.?

Tedicare shows public-source Medicare data for James C. Byrd, M.D., PH.D. (NPI 1679699748), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James C. Byrd, M.D., PH.D. have ACO affiliation data?

James C. Byrd, M.D., PH.D. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), CVS ACO (MSSP, ACO ID A5407), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to James C. Byrd, M.D., PH.D.?

James C. Byrd, M.D., PH.D. is linked to CENTRAL WASHINGTON HEALTH SERVICES ASSOCIATION (billing NPI 1881642239) in the available physician profile data.

Does James C. Byrd, M.D., PH.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.